Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Lica Pharma ApS
APS
Active
CVR 46702255
Tuborg Havnepark 2, 2900
Hellerup
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2026 · <1 year old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Lica Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MS
Mark Sonne Kharazmi
Management
Management
2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
KB
Karin Birgitte Sonne Kharazmi
Board of Directors
Board of Directors
2026
AK
Arsalan Kharazmi
Chairman
Chairman
2026
MS
Mark Sonne Kharazmi
Board of Directors
Board of Directors
2026
Shareholders
Active legal owners
Karin Birgitte Sonne Kharazmi — 50–66.65%
Arsalan Kharazmi — 50–66.65%
100%
Shareholder
Type
Ownership
Votes
Registered
Karin Birgitte Sonne Kharazmi
Individual
50–66.65%
50–66.65%
2026
Arsalan Kharazmi
Individual
50–66.65%
50–66.65%
2026
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Lica Pharma ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
